2018
DOI: 10.18609/cgti.2018.015
|View full text |Cite
|
Sign up to set email alerts
|

Analytical approaches to characterize AAV vector production & purification: Advances and challenges

Abstract: Adeno-associated viral (AAV) vectors have been reported to be a great promise in a large number of clinical trials. Multiple AAV gene products will enter into early and late phase clinical trials. To sustain this, reliable, fast, robust, GMP compliant analytical methods and characterization protocols are needed. Specific analytical assays need to be performed to assess vector productivity, vector purity, biological activity and safety. Besides the potency of the vector, current advances appear to improve the m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(22 citation statements)
references
References 36 publications
0
21
0
Order By: Relevance
“…1 e). With the high precision of the SEC assay taken into account, the error is still within the variability range of the widely-used PCR and ELISA titering methods in samples with even up to ~ 50% light capsids 8 , 21 , 22 . Further, using UV absorbance, the relative percentage of light to heavy capsids was estimated from A260/A280 peak area ratios.…”
Section: Resultsmentioning
confidence: 99%
“…1 e). With the high precision of the SEC assay taken into account, the error is still within the variability range of the widely-used PCR and ELISA titering methods in samples with even up to ~ 50% light capsids 8 , 21 , 22 . Further, using UV absorbance, the relative percentage of light to heavy capsids was estimated from A260/A280 peak area ratios.…”
Section: Resultsmentioning
confidence: 99%
“…This is especially important for validation of assays for in-process control, where the validation should be performed for each matrix individually. ddPCR can be run without prior DNA extraction, which enables fast analysis time and can thus beneficial for fast determination of yield of downstream processes (Dorange and Le Bec, 2018). We have seen that there is actually no matrix interference with ddPCR by downstream (Table 3) or upstream samples (experience from contract research activities).…”
Section: Discussionmentioning
confidence: 99%
“…The total capsid content may be as important as the vector genome titer and to date there is no harmonized method to assay total capsids or the ability to distinguish empty particles from genome containing particles. Separation of AAV particles and quantification of full/empty ratio can be achieved using techniques, such as enzyme linked immunosorbent assay (ELISA), electron microscopy, analytical ultracentrifugation (AUC), and high pressure liquid chromatography (HPLC), where each has its own advantages and limitations (D’Costa et al, 2016; Dorange and Le Bec, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Due to the existence of empty capsids that do not possess therapeutic benefits, titration by viral genome is preferred for clinical dosing, manufacturing, and analytical testing. 2 , 3 , 4 Traditionally, AAV genome titer is determined by qPCR using a plasmid DNA standard. For the past two decades, extensive efforts have been made in improving qPCR standard preparation, sample treatment, and primer/probe design, etc.…”
Section: Introductionmentioning
confidence: 99%